Crossmark

Engineered resveratrol nanoantioxidants: intestinal targeted oral delivery system of mesalazine for inflammatory bowel disease via spatiotemporal-ecological regulation

Crossref DOI link: https://doi.org/10.1007/s42114-025-01519-3

Published Online: 2025-11-26

Published Print: 2025-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Yan, Jun

Yu, Tianyu

Zhao, Xiaoping

Liu, Zhicheng

Sun, Heng

Zhang, Xiaojiang

Liu, Yichen

Wang, Wen

Meng, Lingjie

She, Junjun

Jing, Xunan
Funding

Funding for this research was provided by:

Innovation Capability Support Program of Shaanxi (2024CX-GXPT-12)

Natural Science Basic Research Plan in Shaanxi Province of China (2025JC-YBMS-409)

Institutional Foundation of The First Affiliated Hospital of Xi’an Jiaotong University (2024-QN-18)
License Information

Text and Data Mining valid from 2025-11-26

Version of Record valid from 2025-11-26
More Information

Article History

Received: 6 June 2025

Revised: 29 September 2025

Accepted: 22 October 2025

First Online: 26 November 2025

Declarations

:

: The authors declare no competing interests.

Document is current

Any future updates will be listed below